Slater Technology Fund to invest in Alcinous Pharmaceuticals

By
-

PROVIDENCE – The Slater Technology Fund, along with private angel investors, will invest up to $600,000 in Alcinous Pharmaceuticals, the nonprofit seed fund announced on May 12. University of Rhode Island graduate students Nicholas DaSilva, Kenneth Rose and Benjamin Barlock started Alcinous at URI’s College of Pharmacy in 2017. The company is focused on development

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber
  • Critical RI business news and analysis updated daily.
  • 1 year of print (26 issues).
  • Unlimited access to all subscriber only content on our website, on any device.
  • Free email alerts.
  • Annual Book of Lists Print Edition.
  • All special issues produced during subscription term.

Click Here to purchase a paywall bypass link for this article

RELATED ARTICLESMORE FROM AUTHOR

No posts to display